{"id":"W2168054139","doi":"10.1002/cncr.29773","title":"Risk factors and model for predicting toxicity‐related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2015,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; BC Cancer Agency","funders":"National Cancer Institute; Astellas Pharma; Dana-Farber/Harvard Cancer Center; Sanofi; Amgen; Pfizer; Bristol-Myers Squibb; Bayer Korea; Exelixis; GlaxoSmithKline","keywords":"Medicine; Sunitinib; Discontinuation; Mucositis; Renal cell carcinoma; Internal medicine; Oncology; Sorafenib; Targeted therapy; Vascular endothelial growth factor; Toxicity; Cancer; Hepatocellular carcinoma; VEGF receptors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005948263,0.0005907101,0.001056569,0.001146644,0.0002684936,0.001077524,0.0008837348,0.0005030101,0.001315004],"category_scores_gemma":[0.01361788,0.0002314235,0.002731823,0.001073955,0.0001285607,0.0003935172,0.0006299309,0.0009298198,0.0002083703],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001203257,"about_ca_system_score_gemma":0.001300528,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02016919,"about_ca_topic_score_gemma":0.008035121,"domain_scores_codex":[0.9984289,0.0008565654,0.0001519599,0.0002570551,0.0001937948,0.0001117581],"domain_scores_gemma":[0.9880557,0.008952988,0.00149691,0.0003598546,0.0006213171,0.0005131714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001349626,0.0002509349,0.9642459,0.00007028074,0.0009502362,0.0001069293,0.00004990614,0.02232653,0.00008301924,0.0001281943,0.001744306,0.00869415],"study_design_scores_gemma":[0.0004955357,0.0008437224,0.4988751,0.00007260693,0.001052356,0.0004776656,0.0001720424,0.4954745,0.0002759271,0.0007003695,0.001511671,0.00004846351],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904922,0.0009435076,0.002842508,0.0005003942,0.00002822923,0.00007217654,0.004696386,0.00007170342,0.0003528855],"genre_scores_gemma":[0.9898503,0.0002503269,0.001818499,0.0000631039,0.00002199343,0.00007753316,0.007680364,0.00001550672,0.0002224009],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02016919,"threshold_uncertainty_score":0.04010361,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03554161773124458,"score_gpt":0.2494180104246402,"score_spread":0.2138763926933956,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}